Paper4351979
Activation and inhibition of blood platelet adenylate cyclase by adenosine or by 2-chloroadenosine.
Haslam RJ and 1 other. Life Sci II, 1972. Cited by 139 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Activation and inhibition of blood platelet adenylate cyclase by adenosine or by 2-chloroadenosine. Papers, record 4351979. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4351979
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Activation and inhibition of blood platelet adenylate cyclase by adenosine or by 2-chloroadenosine.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenosine | Major topic |
| Adenylyl Cyclases | Major topic |
| Blood Platelets | Major topic |
| Adenylyl Cyclase Inhibitors | |
| Aminophylline | |
| Carbon Isotopes | |
| Chlorine | |
| Cyclic AMP | |
| Dose-Response Relationship, Drug | |
| Enzyme Activation | |
| Freezing | |
| Humans | |
| Osmolar Concentration | |
| Papaverine | |
| Prostaglandins | |
| Structure-Activity Relationship | |
| Tritium |
Source PubMed
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 139 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 31,684,173 | Blood Platelet Adenosine Receptors as Potential Targets for Anti-Platelet Therapy. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31684173 | PubMed |
| 11,498,527 | Estimation of anti-platelet drugs on human platelet aggregation with a novel whole blood aggregometer by a screen filtration pressure method. | Br J Pharmacol | 2001 | https://conductscience.org/library/papers/11498527 | PubMed |
| 10,768,906 | Intracoronary dipyridamole reduces the incidence of abrupt vessel closure following PTCA: a prospective randomised trial. | Heart | 2000 | https://conductscience.org/library/papers/10768906 | PubMed |
| 6,324,754 | Characterization of the protein kinase activities of human platelet supernatant and particulate fractions. | Biochem J | 1984 | https://conductscience.org/library/papers/6324754 | PubMed |
| 6,289,802 | Effects of adenosine, 2-deoxyadenosine and N6-phenylisopropyladenosine on rat islet function and metabolism. | Biochem J | 1982 | https://conductscience.org/library/papers/6289802 | PubMed |
| 3,525,085 | Current issues in thrombosis prevention with antiplatelet drugs. | Drugs | 1986 | https://conductscience.org/library/papers/3525085 | PubMed |
| 3,117,049 | Detection of 23-27 kDa GTP-binding proteins in platelets and other cells. | Biochem J | 1987 | https://conductscience.org/library/papers/3117049 | PubMed |
| 2,043,931 | Actions of dipyridamole on endogenous and exogenous noradrenaline in the dog mesenteric vein. | Br J Pharmacol | 1991 | https://conductscience.org/library/papers/2043931 | PubMed |
| 833,206 | Membrane changes during cartilage maturation. Increase in 5'-nucleotidase and decrease in adenosine inhibition of adenylate cyclase. | J Cell Biol | 1977 | https://conductscience.org/library/papers/833206 | PubMed |
| 352,114 | Mechanism of platelet function with particular reference to the effects of drugs acting as inhibitors. | Agents Actions | 1978 | https://conductscience.org/library/papers/352114 | PubMed |
| 291,066 | 13-Azaprostanoic acid: a specific antagonist of the human blood platelet thromboxane/endoperoxide receptor. | Proc Natl Acad Sci U S A | 1979 | https://conductscience.org/library/papers/291066 | PubMed |
| 271,970 | Two distinct adenosine-sensitive sites on adenylate cyclase. | Proc Natl Acad Sci U S A | 1977 | https://conductscience.org/library/papers/271970 | PubMed |
| 267,918 | Conformational basis for the activation of adenylate cyclase by adenosine. | Proc Natl Acad Sci U S A | 1977 | https://conductscience.org/library/papers/267918 | PubMed |
| 225,658 | Regulation of adenylate cyclase by adenosine. | Mol Cell Biochem | 1979 | https://conductscience.org/library/papers/225658 | PubMed |
| 215,136 | Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP. | Biochem J | 1978 | https://conductscience.org/library/papers/215136 | PubMed |
| 214,785 | Adenosine analogs inhibit adipocyte adenylate cyclase by a GTP-dependent process: basis for actions of adenosine and methylxanthines on cyclic AMP production and lipolysis. | Proc Natl Acad Sci U S A | 1978 | https://conductscience.org/library/papers/214785 | PubMed |
| 182,608 | Stimulatory and inhibitory effects of cyclic AMP on pancreatic glucagon release from monolayer cultures and the controlling role of calcium. | Diabetologia | 1976 | https://conductscience.org/library/papers/182608 | PubMed |
| 43,480 | Specific binding of 3H-adenosine to rat brain membranes. | Naunyn Schmiedebergs Arch Pharmacol | 1979 | https://conductscience.org/library/papers/43480 | PubMed |
| 41,193 | Adenosine effects upon transmitter release parameters in the Mg2+-paralyzed neuro-muscular junction of frog. | Naunyn Schmiedebergs Arch Pharmacol | 1979 | https://conductscience.org/library/papers/41193 | PubMed |
| 26,887 | Characterization of alpha- and beta-adrenergic receptors linked to human platelet adenylate cyclase. | Naunyn Schmiedebergs Arch Pharmacol | 1978 | https://conductscience.org/library/papers/26887 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4351979
GET https://conductscience.org/api/papers/v1/4351979/authors